208 related articles for article (PubMed ID: 9222053)
1. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Onody C; Matsiota-Bernard P; Nauciel C
J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Moffie BG; Mouton RP
J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Nielsen K; Bangsborg JM; Høiby N
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
[TBL] [Abstract][Full Text] [Related]
8. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
[TBL] [Abstract][Full Text] [Related]
10. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
Barker JE; Farrell ID
J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Baltch AL; Smith RP; Franke MA; Michelsen PB
Antimicrob Agents Chemother; 1998 Dec; 42(12):3153-6. PubMed ID: 9835507
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
14. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
Nimmo GR; Bull JZ
J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
[TBL] [Abstract][Full Text] [Related]
16. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Jung R; Danziger LH; Pendland SL
J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antibiotic susceptibility of Legionella pneumophila isolated from water systems in Poland.
Sikora A; Gładysz I; Kozioł-Montewka M; Wójtowicz-Bobin M; Stańczak T; Matuszewska R; Krogulska B
Ann Agric Environ Med; 2017 Mar; 24(1):66-69. PubMed ID: 28378991
[TBL] [Abstract][Full Text] [Related]
19. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.
Vandewalle-Capo M; Massip C; Descours G; Charavit J; Chastang J; Billy PA; Boisset S; Lina G; Gilbert C; Maurin M; Jarraud S; Ginevra C
Int J Antimicrob Agents; 2017 Nov; 50(5):684-689. PubMed ID: 28782709
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
